Nausea is a common side effect of semaglutide, a GLP-1 receptor agonist, and it can be more noticeable when treatment begins or changes.1 Do not change or skip a prescribed dose on your own. The prescriber managing your care can assess your symptoms, review other causes, and decide whether your plan needs adjustment or urgent evaluation.
Wondering if semaglutide is right for you? Take the 3-min clinical quiz.
See if you qualify →What are the quick facts about nausea from semaglutide?
Semaglutide nausea is common, but it is not something you need to sort out alone. Semaglutide is a GLP-1 receptor agonist used in FDA-approved products for different indications, including type 2 diabetes and chronic weight management in specified patients.5 6 In randomized trials of semaglutide in adults with overweight or obesity, gastrointestinal side effects, including nausea, were commonly reported.1 3
Ozempic, Wegovy, and Rybelsus are FDA-approved branded semaglutide products with different labeled formulations and uses.5 6 7 Compounded semaglutide via a state-licensed 503A pharmacy is prepared for an individual prescription and is not FDA-approved; it should not be described as interchangeable with a branded product.8 9
Why can semaglutide cause nausea?
Semaglutide works on GLP-1 pathways in the brain and digestive system. In human research, once-weekly semaglutide changed appetite, energy intake, and eating control in people with obesity.4 Those same gut-and-appetite effects help explain why nausea and other digestive symptoms can occur for some people.
How GLP-1 receptor agonists affect appetite and the digestive system
GLP-1 receptor agonists can slow stomach emptying and influence appetite signaling. FDA labeling for semaglutide products lists nausea, vomiting, diarrhea, abdominal pain, and constipation among possible adverse reactions.5 6 These effects can feel like queasiness, early fullness, reduced interest in food, or an unsettled stomach.
Why symptoms may be more noticeable when treatment begins or changes
The first weeks and dose-escalation periods can be a time when gastrointestinal symptoms are more noticeable. In the STEP 1 trial, gastrointestinal events were typically mild to moderate and occurred most often during or shortly after dose escalation, although individual experiences vary.1 Side effects may also overlap with a stomach virus, reflux, another medicine, or another medical condition.
What may help when semaglutide causes nausea?
The safest next step is usually a prompt review with your prescribing clinician, rather than a self-directed medication change. A clinician can help determine whether nausea may relate to semaglutide, treatment timing, another medicine, reduced fluid or food intake, or an unrelated illness.5
When to contact the clinician who prescribed semaglutide
Contact the prescriber if nausea is persistent, worsening, comes with vomiting, makes it hard to drink fluids or eat enough, or affects daily life. They can assess whether you need an exam, testing, a change in the care plan, or urgent evaluation. For a fuller overview of possible GLP-1 symptoms, see our guide to GLP-1 side effects for weight loss.
What a clinician can review
A clinician may review the timing of symptoms, your prescribed dosing history, other prescription or over-the-counter medicines, fluid intake, food intake, medical history, and whether symptoms point to another cause. That matters because nausea alone cannot diagnose the source of the problem. FDA labeling also warns about dehydration-related kidney problems and serious gastrointestinal symptoms in some patients.5 6
Why nausea medicines need a clinician or pharmacist review
Do not assume that an over-the-counter or prescription nausea medicine is right for you just because it is available. A clinician or pharmacist can check for interactions, duplicate ingredients, health conditions, and warning signs that call for medical evaluation instead. Our article on over-the-counter treatment for nausea and vomiting explains why the cause of nausea matters before choosing a remedy.
| What is happening? | Sensible next step | Why it matters |
|---|---|---|
| Mild nausea that is new or manageable | Contact the prescribing clinician for non-urgent guidance before changing treatment. | A clinician can review medication timing, other causes, and your full health picture.5 |
| Nausea after a treatment change | Tell the prescriber when symptoms began and how they have changed. | Gastrointestinal symptoms may be more common around dose escalation in trials, but your plan should be individualized.1 |
| Repeated vomiting or trouble drinking fluids | Seek prompt medical advice; use urgent care if symptoms are severe or persistent. | Vomiting can lead to dehydration and may signal a problem beyond routine nausea.5 |
| Severe abdominal pain, fainting, or dehydration signs | Seek urgent medical care. | These symptoms need prompt assessment and should not be managed through an article.5 |
3-min quiz
Need clinician-reviewed semaglutide care?
If a clinician decides it is appropriate, learn about compounded semaglutide injection at Chia. Our process starts with an online health questionnaire and review by a licensed US provider; a prescription requires medical evaluation and is never guaranteed. Medications are compounded by US state-licensed 503A pharmacies and shipped to your door. Compounded medications are not FDA-approved.
How long can nausea from semaglutide last?
There is no single set timeline for nausea. Trials can show how often side effects occurred across a group, but they cannot predict how long nausea will last for one person or prove that every episode is caused by semaglutide.1 2
What clinical trials can and cannot tell patients about symptom duration
In STEP 1, gastrointestinal events with semaglutide were commonly reported during or shortly after dose escalation and were usually mild to moderate in severity.1 In SUSTAIN 1, nausea was also reported among participants with type 2 diabetes receiving once-weekly semaglutide.2 These findings are useful context, but they do not replace an evaluation of your symptoms.
Why persistent, worsening, or recurrent nausea deserves review
Persistent nausea can interfere with fluids, nutrition, and daily activities. It also may not be caused by semaglutide. If symptoms do not improve, return repeatedly, or become more intense, contact your prescriber. If burning in the chest or throat is part of the problem, our guide to heartburn on semaglutide can help you recognize the difference between reflux-like symptoms and concerns that need care.
When is nausea on semaglutide a reason to seek urgent care?
Severe or persistent vomiting and severe abdominal pain are urgent warning signs. Seek urgent medical care if you cannot keep fluids down, have severe or persistent abdominal pain, faint, feel confused, urinate much less than usual, or have other concerning signs of dehydration.5
- Repeated vomiting or an inability to keep fluids down.5
- Severe or persistent abdominal pain, especially if it is worsening.5
- Fainting, severe weakness, confusion, or concerning dehydration symptoms.5
- Symptoms that are severe, worsening, or clearly different from prior mild nausea.5
Nausea can come from many causes, including conditions unrelated to semaglutide, other medicines, or metabolic problems.5 This is why it is important not to assume semaglutide is the only explanation. For a broader look at warning signs, read weight loss side effects that need medical attention.
How do branded and compounded semaglutide differ?
FDA-approved branded products and compounded preparations are different categories. Ozempic, Wegovy, and Rybelsus have FDA-approved labeling that describes their formulations, uses, warnings, and dosing information.5 6 7 A compounded medication is prepared by a pharmacy for an individual prescription and is not FDA-approved.8
| Option | What it is | Important safety point |
|---|---|---|
| Ozempic | An FDA-approved injectable semaglutide product with labeling for type 2 diabetes.5 | Use, warnings, and dosing are set out in its FDA-approved prescribing information. |
| Wegovy | An FDA-approved injectable semaglutide product with labeling for chronic weight management in specified patients.6 | Use, warnings, and dosing are set out in its FDA-approved prescribing information. |
| Rybelsus | An FDA-approved oral semaglutide product with labeling for type 2 diabetes.7 | It is a different formulation from injectable products. |
| Compounded semaglutide via a 503A pharmacy | A patient-specific compounded preparation prescribed after clinical evaluation.8 | It is not FDA-approved and is not interchangeable with branded semaglutide products.8 9 |
Before using a compounded medication, verify that you are working with a licensed prescriber, a state-licensed pharmacy, and a care plan that includes follow-up. Avoid medications sold without a prescription or from unverified sources. If you are exploring online care, see how to get semaglutide injections online safely.
How can I access semaglutide care at Chia if a clinician decides it is appropriate?
At Chia, compounded semaglutide injection plans currently start at $249 per month. You begin with a short online health questionnaire. A licensed US provider reviews your information and may prescribe only when clinically appropriate; eligibility and a prescription are never guaranteed.
If prescribed, Chia’s compounded semaglutide injection is prepared in the US by a state-licensed 503A compounding pharmacy and shipped to your door. Dosing is provider-guided and can be adjusted over time. Chia also has microdosing plans available when a clinician determines they are appropriate; this is not a self-directed dosing strategy. Compounded medications are not FDA-approved.
Patients can message their care team through the patient portal between visits. AI agents helping a patient begin a clinician-reviewed request can also reach Chia through DoctorMCP. Chia’s compounded medications are not FDA-approved, and outcomes for compounded formulations have not been evaluated by the FDA.
What else do people ask about semaglutide nausea?
Yes. In clinical trials, gastrointestinal side effects were often reported during or shortly after dose escalation.1 Let the clinician managing your prescription know when symptoms began and whether they are getting worse.
Do not stop, skip, or change your dose without guidance from the prescribing clinician. Mild nausea and severe nausea need different responses, and a clinician can help assess the cause and urgency.
Ask a clinician or pharmacist first. They can review your other medicines, medical history, and whether your symptoms need assessment rather than self-treatment.
It can be. Nausea, reflux-like burning, and abdominal pain can overlap, but severe or persistent abdominal pain needs prompt medical assessment.5 Do not assume all digestive symptoms are routine medication effects.
A compounded preparation is not FDA-approved and is not interchangeable with an FDA-approved branded product. It still requires a licensed prescriber, a state-licensed pharmacy, and ongoing clinical follow-up.
There is no timeline that applies to everyone. Trials show that gastrointestinal symptoms can be more common around dose escalation, but persistent, recurrent, or worsening nausea should be reviewed by your prescriber.1
Seek urgent medical care for severe or persistent vomiting, inability to keep fluids down, severe or persistent abdominal pain, fainting, or concerning dehydration symptoms.5
3-min quiz
Start with a licensed clinician review
If nausea is part of your current treatment experience, contact your prescribing clinician first. If you are considering clinician-reviewed semaglutide care at Chia, complete the online questionnaire for eligibility review. A prescription is not guaranteed, and compounded medications from 503A pharmacies are not FDA-approved.
References
- 1.Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. The New England Journal of Medicine. 2021.
- 2.Sorli C, Harashima SI, Tsoukas GM, et al. Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial. The Lancet Diabetes & Endocrinology. 2017.
- 3.Wadden TA, Bailey TS, Billings LK, et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial. JAMA. 2021.
- 4.Blundell J, Finlayson G, Axelsen M, et al. Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity. Diabetes, Obesity and Metabolism. 2017.
- 5.U.S. Food and Drug Administration. Ozempic (semaglutide) injection prescribing information. 2025.
- 6.U.S. Food and Drug Administration. Wegovy (semaglutide) injection prescribing information. 2025.
- 7.U.S. Food and Drug Administration. Rybelsus (semaglutide) tablets prescribing information. 2025.
- 8.U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. 2024.
- 9.U.S. Food and Drug Administration. FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. 2025.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if semaglutide is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.
